Table of Content

1. Executive Summary
   1. Global Next Generation Antibody Therapeutics Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Next Generation Antibody Therapeutics Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
   3. Global Next Generation Antibody Therapeutics Market Outlook: Technology
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
         1. Antibody-drug Conjugates (ADCs)
         2. Bispecific Antibodies
         3. Multispecific Antibodies
         4. Nanobodies
         5. Others
      4. Market Attractiveness Analysis: Technology
   4. Global Next Generation Antibody Therapeutics Market Outlook: Therapeutic Area
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019-2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
         1. Oncology
         2. Autoimmune/Inflammatory
         3. Infectious Diseases
         4. Others
      4. Market Attractiveness Analysis: Therapeutic Area
   5. Global Next Generation Antibody Therapeutics Market Outlook: End-user
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
      3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
         1. Hospitals
         2. Biopharma Companies
         3. Academic & Research Institutes
         4. Others
      4. Market Attractiveness Analysis: End-user
5. Global Next Generation Antibody Therapeutics Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
   3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Next Generation Antibody Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Technology
      3. By Therapeutic Area
      4. By End-user
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
   4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
      1. Antibody-drug Conjugates (ADCs)
      2. Bispecific Antibodies
      3. Multispecific Antibodies
      4. Nanobodies
      5. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
      1. Oncology
      2. Autoimmune/Inflammatory
      3. Infectious Diseases
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospitals
      2. Biopharma Companies
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
7. Europe Next Generation Antibody Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Technology
      3. By Therapeutic Area
      4. By End-user
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
      1. Antibody-drug Conjugates (ADCs)
      2. Bispecific Antibodies
      3. Multispecific Antibodies
      4. Nanobodies
      5. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
      1. Oncology
      2. Autoimmune/Inflammatory
      3. Infectious Diseases
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospitals
      2. Biopharma Companies
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
8. East Asia Next Generation Antibody Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Technology
      3. By Therapeutic Area
      4. By End-user
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
      1. Antibody-drug Conjugates (ADCs)
      2. Bispecific Antibodies
      3. Multispecific Antibodies
      4. Nanobodies
      5. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
      1. Oncology
      2. Autoimmune/Inflammatory
      3. Infectious Diseases
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospitals
      2. Biopharma Companies
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
9. South Asia & Oceania Next Generation Antibody Therapeutics Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Technology
      3. By Therapeutic Area
      4. By End-user
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
      1. Antibody-drug Conjugates (ADCs)
      2. Bispecific Antibodies
      3. Multispecific Antibodies
      4. Nanobodies
      5. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
      1. Oncology
      2. Autoimmune/Inflammatory
      3. Infectious Diseases
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospitals
      2. Biopharma Companies
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
10. Latin America Next Generation Antibody Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Technology
       3. By Therapeutic Area
       4. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
       1. Antibody-drug Conjugates (ADCs)
       2. Bispecific Antibodies
       3. Multispecific Antibodies
       4. Nanobodies
       5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
       1. Oncology
       2. Autoimmune/Inflammatory
       3. Infectious Diseases
       4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
       1. Hospitals
       2. Biopharma Companies
       3. Academic & Research Institutes
       4. Others
    7. Market Attractiveness Analysis
11. Middle East & Africa Next Generation Antibody Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Technology
       3. By Therapeutic Area
       4. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
       1. Antibody-drug Conjugates (ADCs)
       2. Bispecific Antibodies
       3. Multispecific Antibodies
       4. Nanobodies
       5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
       1. Oncology
       2. Autoimmune/Inflammatory
       3. Infectious Diseases
       4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
       1. Hospitals
       2. Biopharma Companies
       3. Academic & Research Institutes
       4. Others
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. AbbVie Inc.
          1. Overview
          2. Segments and Product Types
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. AstraZeneca
       3. NBE-Therapeutics AG (Behringer Ingelheim)
       4. Antibody Therapeutics Inc. (JHBP company)
       5. Sino Biological, Inc.
       6. Genmab A/S
       7. abpro
       8. AbTherx, Inc
       9. Nona Biosciences
       10. Numab Therapeutics AG
       11. Zymeworks Inc.
       12. Radiance Biopharma Inc.
       13. Harbour BioMed
       14. Hummingbird Bioscience
       15. Regeneron Pharmaceuticals Inc.
       16. F-star Therapeutics Ltd.
       17. Biocytogen
       18. Akari Therapeutics
       19. Y-BIOLOGICS
       20. Alchemab Ther­a­peu­tics
       21. Aganitha AI Inc.
       22. Eli Lilly and Company
       23. AAX Biotech
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations